- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06017856
Physical Exercise and Nutrition in Functional Gastrointestinal Disorders in Obese Children
The Impact of Physical Exercise and Nutrition on Functional Gastrointestinal Disorders in Obese Children
Study Overview
Status
Intervention / Treatment
Detailed Description
The investigators intend to conduct a prospective observational case-control study of overweight and obese children, aged 6-18 years, followed in the child health and sport center at Meir medical center, Kfar-Saba, Israel.
Overweight and obese subjects, defined as body mass index (BMI) percentile ≥85%, will be offered to participate. Healthy subjects with normal BMI percentile from other pediatric outpatient clinics as well as relatives and friends of physicians from the pediatric division will be enrolled and serve as the control group.
Study visits will be at enrollment and after 3 and 6 months of participation in the intervention program. During the visits the investigators will collect anthropometric measurements (height, weight, BMI, total body fat). Participants (age 10y and above) or their parents (age 6-10y) will fill a validated questionnaire for diagnosis of FGID based on ROME IV criteria. The investigators will also collect data from exercise capability testing and quality of life questionnaires performed regularly (and irrespective of this study) during the intervention program.
The investigators will then compare between subjects who succeeded to those who failed in losing at least 5% of their initial body weight as well as to healthy controls with normal BMI percentile.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Eyal Zifman, MD
- Phone Number: +97297471596
- Email: eyalzi@clalit.org.il
Study Locations
-
-
-
Kfar Saba, Israel, 4464402
- Recruiting
- Meir Medical Center
-
Contact:
- Eyal Zifman, MD
- Phone Number: +97297471596
- Email: eyalzi@clalit.org.il
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- obese / overweight children participating in the life style modification program at the child sport and health center
Exclusion Criteria:
- other known chronic non-functional gastrointestinal conditions (e.g. Celiac disease, inflammatory bowel disease)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
obese and overweight
Overweight and obese subjects, defined as body mass index (BMI) percentile ≥85%, participating the in life-style intervention program in the child sport center at Meir medical center
|
Life style intervention program for the obese/overweight subjects conducted regardless of this study at the child sport and health center at Meir medical center
|
normal weight
normal weight subjects defined as body mass index (BMI) percentile <85%, with no other chronic conditions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnosis of functional gastrointestinal disorder
Time Frame: 6 months
|
The number of participants with a diagnosis of functional gastrointestinal disorder according to the Rome IV criteria
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Eyal Zifman, MD, Meir Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MMC-22-0199
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Functional Gastrointestinal Disorders
-
Umeå UniversityRecruitingFunctional Gastrointestinal DisorderSweden
-
The University of Texas Medical Branch, GalvestonCompletedGastrointestinal Disorders, Functional
-
Chang Gung Memorial HospitalNew Bellus EnterprisesUnknownNeoplasm | Functional Gastrointestinal DisorderTaiwan
-
Dr Anne PayneUniversity of LondonUnknownFunctional Gastrointestinal Disorders in ChildrenUnited Kingdom
-
BayerCompletedA Pharmacy-based Observational Study to Learn More About Iberogast Advance in the Real-world SettingFunctional Dyspepsia | Irritable Bowel Syndrome | Functional Gastrointestinal Disorders Such as Irritable Bowel Syndrome and Functional DyspepsiaGermany
-
Chinese University of Hong KongCompletedFunctional Gastrointestinal DisorderHong Kong
-
Aarhus University HospitalKarolinska InstitutetCompletedFunctional Gastrointestinal DisordersDenmark
-
Bausch Health Americas, Inc.CompletedFunctional Gastrointestinal DisordersUnited States
-
Danone Asia Pacific Holdings Pte, Ltd.ObvioHealthCompletedFunctional Gastrointestinal DisordersThailand
-
BayerCompletedFunctional Gastrointestinal DisordersGermany
Clinical Trials on Life style intervention program
-
Glostrup University Hospital, CopenhagenLundbeck Foundation; Sygekassernes HelsefondCompletedPhysical Activity | Sedentary Behavior | Life StyleDenmark
-
Isfahan University of Medical SciencesCompletedDiabetes Mellitus, Type 2Iran, Islamic Republic of
-
The George InstituteNational Health and Medical Research Council, Australia; All India Institute...CompletedGestational Diabetes Mellitus in PregnancyBangladesh, India, Sri Lanka
-
Novartis PharmaceuticalsCompleted
-
Isfahan University of Medical SciencesCompletedDiabetes Mellitus, Type 2Iran, Islamic Republic of
-
University of British ColumbiaCompleted
-
Soroka University Medical CenterUnknown
-
Claus Bogh JuhlOdense University Hospital; Steno Diabetes Center OdenseRecruiting
-
University of California, San FranciscoSan Francisco Department of Public Health; San Francisco General Hospital; Sonoma...CompletedType 2 Diabetes Mellitus | Gestational Diabetes MellitusUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Recruiting